Glycinorm-M 80 Tablet
By Glycinorm-M
Rx
15 Tablet in a Strip

Composition
Gliclazide(80mg) + Metformin(500mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
May, 2026

liver
When using Meclazide M 80mg/500mg Tablet, it is important to be cautious if you have liver disease. Patients with liver conditions may require a dose adjustment when taking Meclazide M 80mg/500mg Tablet. It is advisable to consult your doctor before starting this medication. Typically, Meclazide M 80mg/500mg Tablet is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not recommended for use in patients with severe liver disease. Make sure to follow your healthcare provider's guidance closely to ensure the safe and effective use of Meclazide M 80mg/500mg Tablet.

kidney
Meclazide M 80mg/500mg Tablet should be used with caution if you have kidney disease. Your doctor may need to adjust the dose. Avoid using this medicine if you have severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

alcohol
Caution should be taken when consuming alcohol with Meclazide M 80mg/500mg Tablet.

driving
If you experience low or high blood sugar symptoms, avoid driving while taking Meclazide M 80mg/500mg Tablet.

pregnancy
Meclazide M 80mg/500mg Tablet is not safe to use during pregnancy due to potential risk to the baby. In rare life-threatening cases, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Caution is advised when breastfeeding while using Meclazide M 80mg/500mg Tablet, as it may be unsafe. Limited data indicates potential harm to the baby through breastmilk exposure.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹232.4
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024